Lixte Biotechnology Stock Forecast - Accumulation Distribution

LIXTW Stock  USD 0.03  0  21.30%   
Lixte Stock Forecast is based on your current time horizon.
  
Asset Turnover is likely to drop to 0.26 in 2024. Common Stock Shares Outstanding is likely to drop to about 1.8 M in 2024. Net Loss is likely to drop to about (3.1 M) in 2024.
On November 21, 2024 Lixte Biotechnology Holdings had Accumulation Distribution of 800.0. The accumulation distribution (A/D) indicator shows the degree to which Lixte Biotechnology is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Lixte Biotechnology Holdings to determine if accumulation or reduction is taking place in the market. This value is adjusted by Lixte Biotechnology trading volume to give more weight to distributions with higher volume over lower volume.
Check Lixte Biotechnology VolatilityBacktest Lixte BiotechnologyTrend Details  

Lixte Biotechnology Trading Date Momentum

On November 22 2024 Lixte Biotechnology Holdings was traded for  0.02  at the closing time. The highest daily price throughout the period was 0.02  and the lowest price was  0.02 . The daily volume was 300. The net trading volume on 11/22/2024 added to the next day price reduction. The trading delta at closing time to closing price of the next trading day was 17.86% . The trading delta at closing time to current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Lixte Biotechnology to competition

Other Forecasting Options for Lixte Biotechnology

For every potential investor in Lixte, whether a beginner or expert, Lixte Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lixte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lixte. Basic forecasting techniques help filter out the noise by identifying Lixte Biotechnology's price trends.

Lixte Biotechnology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lixte Biotechnology stock to make a market-neutral strategy. Peer analysis of Lixte Biotechnology could also be used in its relative valuation, which is a method of valuing Lixte Biotechnology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Lixte Biotechnology Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lixte Biotechnology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lixte Biotechnology's current price.

Lixte Biotechnology Market Strength Events

Market strength indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on investment. By undertsting and applying Lixte Biotechnology stock market strength indicators, traders can identify Lixte Biotechnology Holdings entry and exit signals to maximize returns.

Lixte Biotechnology Risk Indicators

The analysis of Lixte Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lixte Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lixte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lixte Stock Analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.